← Back to Search

Mother's Recorded Voice for Premature Infants

N/A
Waitlist Available
Led By Narendra Dereddy, MD
Research Sponsored by AdventHealth
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 23 days
Awards & highlights

Study Summary

This trial is testing whether playing a recording of the mother's voice to premature babies in the NICU will help improve the mother's depression, anxiety, stress, and overall feeling about her baby.

Who is the study for?
This trial is for mothers over 18 with preterm infants born between 26 and nearly 31 weeks of gestation, without major congenital or chromosomal anomalies. The mothers must be willing to record their voice and complete questionnaires about their feelings and stress levels.Check my eligibility
What is being tested?
The study tests the effect of playing a mother's recorded voice to her extremely preterm infant in the NICU when she can't be there. It aims to see if this can reduce maternal depression, anxiety, stress, and improve feelings towards the baby.See study design
What are the potential side effects?
There are no direct medical side effects expected from this intervention as it involves only playing audio recordings. However, emotional responses may vary among participants.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 23 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 23 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Maternal response to Depression, Anxiety, and Stress Scale(DASS)
Secondary outcome measures
Feelings questionnaire
Incidence of apneas, bradycardias and desaturation episodes

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Maternal voiceExperimental Treatment1 Intervention
Mother's voice will be played for 1 week between week 2 and 3 of life
Group II: ControlActive Control1 Intervention
NO intervention between week 2 and 3

Find a Location

Who is running the clinical trial?

DraegerUNKNOWN
1 Previous Clinical Trials
22 Total Patients Enrolled
AdventHealthLead Sponsor
105 Previous Clinical Trials
29,144 Total Patients Enrolled
Narendra Dereddy, MDPrincipal InvestigatorAdventHealth
1 Previous Clinical Trials
80 Total Patients Enrolled

Media Library

Maternal voice Clinical Trial Eligibility Overview. Trial Name: NCT04559620 — N/A
Postpartum Depression Research Study Groups: Maternal voice, Control
Postpartum Depression Clinical Trial 2023: Maternal voice Highlights & Side Effects. Trial Name: NCT04559620 — N/A
Maternal voice 2023 Treatment Timeline for Medical Study. Trial Name: NCT04559620 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have been enlisted for this research endeavor?

"Affirmative, according to records on clinicaltrials.gov this study is still accepting patients. Initially posted in March 25th 2021 and last modified April 22nd 2022, the trial seeks 40 participants from 1 site."

Answered by AI

Are medical professionals still accepting volunteers for this research endeavor?

"Yes, the information available on clinicaltrials.gov states that this research is actively recruiting suitable candidates. It was initially listed on March 25th 2021 and has been updated as recently as April 22nd 2022 for enrollment of 40 individuals from a single site."

Answered by AI
Recent research and studies
~17 spots leftby Mar 2025